ReviewClinical cardiology2020
Point-of-care ultrasound: Closing guideline gaps in screening for valvular heart disease.
Review in Clinical cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07339007 (Observational Study to Validate a Family Physician Echocardiography Training Programme), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Observational Study to Validate a Family Physician Echocardiography Training Programme
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- Management of Echocardiography Requests for the Detection and Follow-Up of Heart Valve Disease: A Consensus Statement From the British Heart Valve Society.Clinical cardiology · 2025Guideline
- Proposing the ValvUS approach: integrating bedside tests and ultrasonography for severe valvular heart disease diagnosis.Einstein (Sao Paulo, Brazil) · 2026Review
- Heart murmurs in the general population: diagnostic value and prevalence from the Tromsø Study.Heart (British Cardiac Society) · 2025Article
- Feasibility and utilization of point-of-care ultrasound devices in a prehospital setting in Riyadh, Saudi Arabia.Saudi medical journal · 2025Article
- Point-of-care ultrasound vs. routine transthoracic echocardiography for screening of cardiovascular disease in pregnant women.European heart journal. Imaging methods and practice · 2025Article
- Critical Care Ultrasound in Shock: A Comprehensive Review of Ultrasound Protocol for Hemodynamic Assessment in the Intensive Care Unit.Journal of clinical medicine · 2024Review
- Point-of-Care Ultrasound for the Diagnosis of Frequent Cardiovascular Diseases: A Review.Cureus · 2023Review
- Diagnostic Accuracy of Cardiac Point-of-Care Ultrasound in a Tertiary Medical Intensive Care Unit.Critical care explorations · 2023Article
- Building Consensus on the Point-of-Care Ultrasound Skills Required for Effective Healthcare Service Delivery at District Hospitals in South Africa: A Delphi Study.International journal of environmental research and public health · 2023Article
- Gaps, Obstacles, and Opportunities in Rheumatic Heart Disease Research: Where Are We Now?JACC. Advances · 2023Article
- Article
- Article
- Evaluating Medical Therapy for Calcific Aortic Stenosis: JACC State-of-the-Art Review.Journal of the American College of Cardiology · 2021Review
- Point-of-care ultrasound: Closing guideline gaps in screening for valvular heart disease.Clinical cardiology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA linear increase in the number of valvular heart disease is expected due to the aging population, yet most patients with severe valvular heart disease remain undiagnosed. HYPOTHESIS: POCUS can serve as a screening tool for valvular heart disease.
methodsWe reviewed the literature to assess the strengths and limitations of POCUS in screening and diagnosing valvular heart disease.
resultsPOCUS is an accurate, affordable, accessible, and comprehensive tool. It has a fast learning curve and can prevent unnecessary and more expensive imaging. Challenges include training availability, lack of simplified screening protocols, and reimbursement. Large scale valvular screening data utilizing POCUS is not available.
conclusionPOCUS can serve as a screening tool and guide the management of patients with valvular heart disease. More data is needed about its efficacy and cost-effectiveness in the screening of patients with valvular heart disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.